首页> 外文期刊>Journal of the European Academy of Dermatology and Venereology: JEADV >Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis

【24h】

Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis

机译：Dupilumab治疗患者在具有特应性皮炎和严重的特征角膜炎炎

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

著录项
引文网络
相似文献
相关主题

著录项

来源
《Journal of the European Academy of Dermatology and Venereology: JEADV》 |2020年第6期|共3页
作者

展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类皮肤病学与性病学;
关键词

相似文献

外文文献
中文文献
专利

1. Dupilumab therapy in a patient with atopic dermatitis and severe atopic keratoconjunctivitis [J] . Journal of the European Academy of Dermatology and Venereology: JEADV . 2020,第6期

机译：Dupilumab治疗患者在具有特应性皮炎和严重的特征角膜炎炎
2. Dupilumab therapy provides clinically meaningful improvement in patient-reported outcomes (PROs): A phase IIb, randomized, placebo-controlled, clinical trial in adult patients with moderate to severe atopic dermatitis (AD) [J] . Simpson Eric L., Gadkari Abhijit, Worm Margitta, Journal of the American Academy of Dermatology . 2016,第3期

机译：Dupilumab治疗可为患者报告的结局（PRO）提供临床上有意义的改善：一项针对中度至重度特应性皮炎（AD）成年患者的IIb期，随机，安慰剂对照的临床试验
3. Efficacy and safety of dupilumab monotherapy in adults with moderate-to-severe atopic dermatitis: a pooled analysis of two phase 3 randomized trials (LIBERTY AD SOLO 1 and LIBERTY AD SOLO 2) [J] . Thaci Diamant, Simpson Eric L., Deleuran Mette, Journal of dermatological science . 2019,第2期

机译：杜帕里姆单疗法在成人中具有中度至严重的特征性皮炎的疗效和安全性：两相3阶段随机试验的汇总分析（Liberty Ad Solo 1和Liberty Ad Solo 2）
4. Clinical Improvement and Immunological Changes of Atopic Dermatitis in Patients Undergoing Subcutaneous Immunotherapy with Depigmented Polymerized House Dust Mite Allergens [C] . C. Bussmann, AJ. Hart, S. Vrtala, Collegium Internationale Allergologicum . 2007

机译：用沉淀聚合房屋粉尘螨过敏原患者检查患者特应性皮炎的临床改善和免疫变化
5. Genetic determinants of Staphylococcus aureus colonization in Atopic Dermatitis patients. [D] . Yeung, Melinda K. 2008

机译：特应性皮炎患者中金黄色葡萄球菌定植的遗传决定因素。
6. Remission of severe atopic dermatitis with dupilumab and rescue tofacitinib therapy [O] . Danielle M. Peterson, Matthew D. Vesely 2021

机译：用杜帕里米布缓解严重的特应性皮炎拯救Tofacitinib治疗
7. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2 [O] . Michael J. Cork, Laurent Eckert, Eric L. Simpson, 2019

机译：杜帕米布改善了患者报告的特应性皮炎的症状，焦虑症状和抑郁症的症状，中度至严重的特应性皮炎中的健康相关的生活质量：从随机试验SOLO 1和SOLO 2的汇总数据分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号